Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
Accenture
Fuji
Healthtrust
Teva
Chubb
Citi
Boehringer Ingelheim
Queensland Health

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,441,958

« Back to Dashboard

Summary for Patent: 5,441,958
Title: Ophthalmic compositions comprising emedastine and methods for their use
Abstract:Topical ophthalmic compositions comprising 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole and its ophthalmically acceptable acid addition salts have been found to be useful in treating allergic conjunctivitis and related ailments.
Inventor(s): Yanni; John M. (Burleson, TX), Robertson; Stella M. (Arlington, TX), Okumura; Shigetoshi (Nara, JP), Tanaka; Hitoshi (Nara, JP), Saito; Tadayuki (Osaka, JP)
Assignee: Alcon Laboratories, Inc. (Fort Worth, TX)
Application Number:08/163,973
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,441,958

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,441,958

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan4-329216Dec 09, 1992

International Patents Family Members for US Patent 5,441,958

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 185696 ➤ Try a Free Trial
Australia 5744294 ➤ Try a Free Trial
Australia 667613 ➤ Try a Free Trial
Canada 2151385 ➤ Try a Free Trial
Germany 69326840 ➤ Try a Free Trial
Denmark 0673250 ➤ Try a Free Trial
European Patent Office 0673250 ➤ Try a Free Trial
Spain 2137352 ➤ Try a Free Trial
Greece 3032264 ➤ Try a Free Trial
Hong Kong 1013964 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Fuji
Harvard Business School
Merck
Colorcon
Healthtrust
Chinese Patent Office
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot